Soberana 2 or Sovereign 2 is a COVID-19 vaccine developed by Cuba. The vaccine has 91 per cent efficacy against symptomatic COVID-19 cases when delivered with the booster shot Soberana Plus. If this vaccine is approved, Cuba will become the first Latin American country to manufacture and produce COVID-19 vaccine.
The vaccine was developed by the Finlay Institute in collaboration with the Centre for Molecular Immunology and the National Biopreparations Centre. It will be administered via three shots, with one being Soberana Plus. It is one of the five vaccine candidates that are being developed in the island nation with a population of 11 million.